153 related articles for article (PubMed ID: 31415377)
1. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments.
Nishida S; Tsuboi A; Tanemura A; Ito T; Nakajima H; Shirakata T; Morimoto S; Fujiki F; Hosen N; Oji Y; Kumanogoh A; Kawase I; Oka Y; Azuma I; Morita S; Sugiyama H
Medicine (Baltimore); 2019 Aug; 98(33):e16771. PubMed ID: 31415377
[TBL] [Abstract][Full Text] [Related]
2. A retrospective study of immunotherapy using the cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin (BCG-CWS) for cervical cancer.
Shibata T; Takata E; Sakamoto J; Shioya A; Yamada S; Takakura M; Sasagawa T
Medicine (Baltimore); 2022 Dec; 101(52):e32481. PubMed ID: 36595982
[TBL] [Abstract][Full Text] [Related]
3. Innate immune therapy with a Bacillus Calmette-Guérin cell wall skeleton after radical surgery for non-small cell lung cancer: a case-control study.
Kodama K; Higashiyama M; Takami K; Oda K; Okami J; Maeda J; Akazawa T; Matsumoto M; Seya T; Wada M; Toyoshima K
Surg Today; 2009; 39(3):194-200. PubMed ID: 19280277
[TBL] [Abstract][Full Text] [Related]
4. Application of BCG-CWS as a Systemic Adjuvant by Using Nanoparticulation Technology.
Masuda H; Nakamura T; Noma Y; Harashima H
Mol Pharm; 2018 Dec; 15(12):5762-5771. PubMed ID: 30380885
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterial cell-wall skeleton as a universal vaccine vehicle for antigen conjugation.
Paik TH; Lee JS; Kim KH; Yang CS; Jo EK; Song CH
Vaccine; 2010 Nov; 28(50):7873-80. PubMed ID: 20937311
[TBL] [Abstract][Full Text] [Related]
6. Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton.
Matsumoto M; Seya T; Kikkawa S; Tsuji S; Shida K; Nomura M; Kurita-Taniguchi M; Ohigashi H; Yokouchi H; Takami K; Hayashi A; Azuma I; Masaoka T; Kodama K; Toyoshima K; Higashiyama M
Int Immunopharmacol; 2001 Aug; 1(8):1559-69. PubMed ID: 11515819
[TBL] [Abstract][Full Text] [Related]
7. Immunotherapy of ovarian cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin: effect of lymphadenectomy.
Hayashi A; Nishida Y; Yoshii S; Kim SY; Uda H; Hamasaki T
Cancer Sci; 2009 Oct; 100(10):1991-5. PubMed ID: 19656158
[TBL] [Abstract][Full Text] [Related]
8. Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin.
Yasumoto K; Manabe H; Yanagawa E; Nagano N; Ueda H; Hirota N; Ohta M; Nomoto K; Azuma I; Yamamura Y
Cancer Res; 1979 Aug; 39(8):3262-7. PubMed ID: 222448
[TBL] [Abstract][Full Text] [Related]
9. Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS).
Yamamura Y; Sakatani M; Ogura T; Azuma I
Cancer; 1979 Apr; 43(4):1314-9. PubMed ID: 221088
[TBL] [Abstract][Full Text] [Related]
10. Bacillus calmette-guerin cell wall cytoskeleton enhances colon cancer radiosensitivity through autophagy.
Yuk JM; Shin DM; Song KS; Lim K; Kim KH; Lee SH; Kim JM; Lee JS; Paik TH; Kim JS; Jo EK
Autophagy; 2010 Jan; 6(1):46-60. PubMed ID: 19901560
[TBL] [Abstract][Full Text] [Related]
11. Clinical and molecular insights into BCG immunotherapy for melanoma.
Kremenovic M; Schenk M; Lee DJ
J Intern Med; 2020 Dec; 288(6):625-640. PubMed ID: 32128919
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy of cancer with cell wall skeleton of Myocabacterium bovis-Bacillus Calmette-Guérin: experimental and clinical results.
Yamamura Y; Azuma I; Taniyama T; Sugimura K; Hirao F; Tokuzen R; Okabe M; Nakahara W; Yasumoto K; Ohta M
Ann N Y Acad Sci; 1976; 277(00):209-27. PubMed ID: 826205
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of immunologic tumor regression by intratumoral administration of dendritic cells in combination with cryoablative tumor pretreatment and Bacillus Calmette-Guerin cell wall skeleton stimulation.
Udagawa M; Kudo-Saito C; Hasegawa G; Yano K; Yamamoto A; Yaguchi M; Toda M; Azuma I; Iwai T; Kawakami Y
Clin Cancer Res; 2006 Dec; 12(24):7465-75. PubMed ID: 17189420
[TBL] [Abstract][Full Text] [Related]
14. Gene-inducing program of human dendritic cells in response to BCG cell-wall skeleton (CWS), which reflects adjuvancy required for tumor immunotherapy.
Ishii K; Kurita-Taniguchi M; Aoki M; Kimura T; Kashiwazaki Y; Matsumoto M; Seya T
Immunol Lett; 2005 May; 98(2):280-90. PubMed ID: 15860229
[TBL] [Abstract][Full Text] [Related]
15. The liposome-incorporating cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guéin can directly enhance the susceptibility of cancer cells to lymphokine-activated killer cells through up-regulation of natural-killer group 2, member D ligands.
Miyazaki J; Kawai K; Kojima T; Oikawa T; Joraku A; Shimazui T; Nakaya A; Yano I; Nakamura T; Harashima H; Akaza H
BJU Int; 2011 Nov; 108(9):1520-6. PubMed ID: 21314815
[TBL] [Abstract][Full Text] [Related]
16. Immunotherapy of human malignant melanoma with oil-attached BCG cell-wall skeleton.
Yamamura Y; Yoshizaki K; Azuma I; Yagura T; Watanabe T
Gan; 1975 Aug; 66(4):355-63. PubMed ID: 1102379
[TBL] [Abstract][Full Text] [Related]
17. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors.
Tsuji S; Matsumoto M; Takeuchi O; Akira S; Azuma I; Hayashi A; Toyoshima K; Seya T
Infect Immun; 2000 Dec; 68(12):6883-90. PubMed ID: 11083809
[TBL] [Abstract][Full Text] [Related]
18. Development of immunoadjuvants for immunotherapy of cancer.
Azuma I; Seya T
Int Immunopharmacol; 2001 Jul; 1(7):1249-59. PubMed ID: 11460306
[TBL] [Abstract][Full Text] [Related]
19. Bacillus Calmette-Guérin cell-wall skeleton enhances the killing activity of cytotoxic lymphocyte-activated human dendritic cells transduced with the prostate-specific antigen gene.
Fujii R; Iwahashi M; Kikkawa K; Inagaki T; Kohjimoto Y; Ojima T; Mori T; Kuramoto T; Nishizawa S; Azuma I; Yamaue H; Shinka T; Hara I
BJU Int; 2009 Dec; 104(11):1766-73. PubMed ID: 20063450
[TBL] [Abstract][Full Text] [Related]
20. WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone.
Nakajima H; Kawasaki K; Oka Y; Tsuboi A; Kawakami M; Ikegame K; Hoshida Y; Fujiki F; Nakano A; Masuda T; Wu F; Taniguchi Y; Yoshihara S; Elisseeva OA; Oji Y; Ogawa H; Azuma I; Kawase I; Aozasa K; Sugiyama H
Cancer Immunol Immunother; 2004 Jul; 53(7):617-24. PubMed ID: 15175906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
